CVTX - CV Therapeutics, Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CVTX - CV Therapeutics, Inc.

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: mopgcw who wrote (69)	1/21/2003 7:50:32 PM
From: A.J. Mullen	of 411

I was impressed by the presentation at H&Q. I've just seen a report by Morgan Stanley. MS are worried by the Qt (interval b/n the heart firing and recovery) prolongation seen with Ranexa. The CVTX speaker addressed the Qt issue and claimed they did not think the FDA would be unduly concerned. If I remember right, the argument was that the prolongation was small compared to the range. I'm not sure that I accept that. Would anyone with some medical knowledge care to address this.? Ashley

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next